Bagshaw MA: External radiation therapy of carcinoma of the prostate. Cancer45 (suppl):1912-1920, 1980
2.
Beck JR, Kassirer JP, Pauker SG: A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making. Am J Med73:883-888, 1982
3.
Beck JR, Pauker SG: The Markov process in medical prognosis. Med Decis Making3:419-458, 1983
4.
Boxer RJ, Kaufmann JJ, Goodwin WE: Radical prostatectomy for carcinoma of the prostate: 1951-1976. A review of 329 patientsJ Urol117:208-213, 1977
5.
Byar DP, Mostofi FK, Veterans Administration Cooperative Urological Research Group: Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies examined by the step-section technique. Cancer30:5-13, 1972
6.
Centers for Disease Control: Human immunodeficiency virus infection in the United States. MMWR36:801-804, 1987
7.
Correa RJ Jr, Gibbons RP, Cummings KB, et al: Total prostatectomy for stage B carcinoma of the prostate. J Urol117:328-329, 1977
8.
Culp OS, Meyer JJ: Radical prostatectomy in the treatment of prostatic cancer. Cancer32:1113-1118, 1973
9.
Cupps RE, Utz DC, Fleming TR, et al: Definitive radiation therapy for prostatic carcinoma: the Mayo Clinic experience . J Urol124:855-859, 1980
10.
Flocks RH, Culp D., Port R.: Lymphatic spread from prostatic cancer. J Urol81:194-196, 1959
11.
Geberding JL , Sande MA: Real and perceived risks of AIDS in the health care and work environment. In: Information on AIDS for the Practicing Physician. Chicago, AMA, 1987, pp 9-21
12.
Geberding JL , Bryant-LeBlanc CE, Nelson K., et al: Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions . J Infect Dis156:1-8, 1987
13.
Gleason DF, Mellinger GT, Veterans Administration Cooperative Urological Research Group: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol111:58-64, 1974
14.
Goedert JJ, Biggar RJ, Weiss SH, et al: Three-year incidence of AIDS in five cohorts of HTLV-III infected risk group membersScience231:992-995, 1986
15.
Hagen MD, Meyer KB, Pauker SG: Routine preoperative screening for HN: Does the risk to the surgeon outweigh the risk to the patient?JAMA259:1357-1359, 1988
16.
Harisiadis L. , Veenema RJ, Senyszyn JJ, et al: Carcinoma of the prostate: treatment with external radiotherapy. Cancer41:2131-2142, 1978
17.
Harza TA, Giri S.: Prophylactic pelvic girdle irradiation in the treatment of prostatic carcinoma . Int J Radiat Oncol Biol Phys7:817-819, 1981
18.
Henderson DK , Saah AJ, Zak BJ, et al: Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers. Ann Intern Med104:644-647, 1986
19.
Hirsch MS, Wormser GP, Schooley RT, et al: Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III) . N Engl J Med312:1-4, 1985
20.
Jaffe HW, Darrow WW, Echenberg DF, et al : The acquired immunodeficiency syndrome in a cohort of homosexual men: a six-year follow-up study. Ann Intern Med103:210-214, 1985
21.
Jewett HJ: The present status of radical prostatectomy for stages A and B prostatic cancer. Urol Clin North Am2:105-124, 1975
22.
Jewett HJ, Bridge RW, Gray GF Jr, et al: The palpable nodule of prostatic cancer: results 15 years after radical excision . JAMA203:403-406, 1968
23.
Kane RD, Paulson DF: Radioisotope bone scanning characteristics of metastatic skeletal deposits of prostatic adenocarcinoma. J Urol117:618-621, 1977
24.
Kim HC, Hahum K., Raska K. Jr, et al: Natural history of acquired immunodeficiency syndrome in hemophilic patients . Am J Hematol24:169-176, 1987
25.
Kuhls TL, Viker S.Parris NB, et al: Occupational risk of HIV, HBV and HSV-2 infections in health care personnel caring for AIDS patients. Am J Pub Health77:1306-1309, 1987
26.
Lui KJ, Lawrence DN, Morgan WM, et al: A model-based approach for estimating the mean incubation period of transfusion-associated acquired immunodeficiency syndromeProc Natl Acad Sci USA83:3051-3055, 1986
27.
Marasca G., McEvoy M.: Length of survival of patients with acquired immune deficiency syndrome in the United Kingdom. Br Med J292:1727-1729, 1986
28.
McCray E.: Occupational risk of the acquired immunodeficiency syndrome among health care workersN Engl J Med314:1127-1132, 1986
29.
McEvoy M., Porter K., Mortimer P., et al: Prospective study of clinical, laboratory, and ancillary staff with accidental exposures to blood or body fluids from patients infected with HIVBr Med J294:1595-1597, 1987
30.
McNeal JE: Origin and development of carcinoma in the prostate. Cancer23:24-34, 1969
31.
Moss AR, McCallum G., Volberding PA, et al : Mortality ajssociated with mode of presentation in the acquired immune deficiency syndromeJ Natl Cancer Inst73:1281-1284, 1984
32.
Mostofi FK: Grading of prostatic carcinoma. Cancer Chemother Ther59:111-117, 1975
33.
Olsson CA: Staging lymphadenectomy should be an antecedent to treatment in localized prostatic carcinoma. Urology25(suppl 2):4-6, 1985
34.
Olsson CA, Babayan R., White RD: Management of stage B or C prostatic carcinoma: radical surgery versus radiotherapyUrology25 (suppl 2):30-35, 1985
35.
Paulson DF: Staging lymphadenectomy should not be an antecedent to treatment in localized prostatic carcinoma. Urology25 (suppl 2):7-14, 1985
36.
Paulson DF, Lin GH, Hinshaw W., et al, and The Uro-oncology Research Group: Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol128:502-504, 1982
37.
Peeling WB, Griffiths GJ, Evans KT, et al: Diagnosis and staging of prostatic cancer by transrectal ultrasonography. A preliminary study. Br J Urol51:565-569, 1979
38.
Perez CA, Fair WR, Ihde DC, et al: Cancer of the prostate In: DeVita VT Jr, Hellman S, Rosenberg SA (edsl: Cancer: Principles and Practice of Oncology. Philadelphia, J. B. Lippincott, 1985, pp 929-964
39.
Perez CA, Bauer W., Garza R., et al: Radiation therapy in the definitive treatment of localized carcinoma of the prostateCancer40:1425-1433, 1978
40.
Pickney DS: CDC: Health worker AIDS risk from needles is less than 1%AMA News, Dec 18, 1987
41.
Pilepich MV , Perez CA, Walz BJ, et al: Complications of definitive radiotherapy for carcinoma of the prostateInt J Radiat Oncol Biol Phys7:1341-1348, 1981
42.
Polk BF, Fox R., Brookmeyer R., et al : Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med316:61-66, 1987
43.
Ray GR, Bagshaw MA: The role of radiation therapy in the definitive treatment of adenocarcinoma of the prostate. Annu Rev Med26:567-588, 1975
44.
Ray GR, Cassady JR, Bagshaw MA: Definitive radiation therapy of carcinoma of the prostate. A report on 15 years experience. Radiology106:407-418, 1973
45.
Rivin BE, Monroe JM, Hubschman BP, et al : AIDS outcome: a first follow-up. N Engl J Med311:857, 1984
46.
Rothenberg R., Woelfel M., Stoneburner R., et al: Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. N Engl J Med317:1297-1302, 1987
47.
Scott R. Jr, Mutchnik DL, Laskowski TZ, et al: Carcinoma of the prostate in elderly men: incidence, growth, characteristics and clinical significance . J Urol101:602-607, 1969
48.
Shipley WU, Schartz JH, Zinnan LH, et al: Cancer of the prostate. In: Cady B (ed): Cancer Manual.Boston, American Cancer Society, Massachusetts Division , 1986, pp 250-259
49.
Stevens CE, Taylor PE, Zang EA, et al: Human T-cell lymphotrophic virus type III infection in a cohort of homosexual men in New York City. JAMA255:2167-2172, 1986
50.
Taylor WJ, Richardson RG, Hafermann MD: Radiation therapy for localized prostate cancer. Cancer43:1123-1127, 1979
51.
Walsh TC: Radical prostatectomy with the preservation of sexual function. Urology Letter Club, March 24, 1983
52.
Walsh PC, Jewett HJ: Radical surgery for prostatic cancer. Cancer45:1906-1911, 1980
53.
Weiss SH, Saxinger WC, Rechtman D., et al: HTLV-III infection among health care workers. Association with needle-stick injuries. JAMA254:2089-2093, 1985
54.
White RD, Paulson DF, Glenn JR: The clinical spectrum of prostatic cancer. J Urol117:323-327, 1977
55.
Whitmore WF Jr: Hormone therapy in prostatic cancer. Am J Med21:697-713, 1956
56.
Yan LT: Clinical significance of human acid phosphatase: a review. Am J Med56:604-616, 1974